Grupo de investigación en enfermedades raras respiratorias
ERR
Centro de Investigación Biomédica en Red sobre Enfermedades Raras
Madrid, EspañaCentro de Investigación Biomédica en Red sobre Enfermedades Raras -ko ikertzaileekin lankidetzan egindako argitalpenak (11)
2024
-
Developments in pharmacogenetics, pharmacogenomics, and personalized medicine
Pharmacological Research, Vol. 200
2021
2020
-
Immunofluorescence analysis as a diagnostic tool in a spanish cohort of patients with suspected primary ciliary dyskinesia
Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-14
-
Recurrent wheezing during the first 3 years of life in a birth cohort of moderate-to-late preterm infants
Pediatric Allergy and Immunology, Vol. 31, Núm. 2, pp. 124-132
2019
-
Role of Immunofluorescence and Molecular Diagnosis in the Characterization of Primary Ciliary Dyskinesia
Archivos de Bronconeumologia
2014
-
Decreased cell proliferation and higher oxidative stress in fibroblasts from down syndrome fetuses. Preliminary study
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, Núm. 1, pp. 116-125
2013
-
Histone H3 glutathionylation in proliferating mammalian cells destabilizes nucleosomal structure
Antioxidants and Redox Signaling, Vol. 19, Núm. 12, pp. 1305-1320
-
Lafora disease fibroblasts exemplify the molecular interdependence between thioredoxin 1 and the proteasome in mammalian cells
Free Radical Biology and Medicine, Vol. 65, pp. 347-359
-
Nuclear glutathione
Biochimica et Biophysica Acta - General Subjects, Vol. 1830, Núm. 5, pp. 3304-3316
2012
-
Evaluation of the quality of publications on randomized clinical trials using the Consolidated Standards of Reporting Trials (CONSORT) statement guidelines in a Spanish Tertiary Hospital
Journal of Clinical Pharmacology, Vol. 52, Núm. 7, pp. 1106-1114